Dr Graham Baluh, MD in Jber, AK - Medicare Surgery

Dr Graham Baluh, MD is a medicare enrolled "Surgery" physician in Jber, Alaska. His current practice location is 5955 Zeamer Ave, Jber, Alaska. You can reach out to his office (for appointments etc.) via phone at (315) 580-1243.

Dr Graham Baluh is licensed to practice in Oklahoma (license number 32679) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1881072148.

Contact Information

	Dr Graham Baluh, MD
	5955 Zeamer Ave, Jber, AK 99506-3702
	(315) 580-1243
	Not Available

Physician's Profile

Full Name	Dr Graham Baluh
Gender	Male
Speciality	Surgery
Location	5955 Zeamer Ave, Jber, Alaska
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1881072148
Provider Enumeration Date: 05/07/2015
Last Update Date: 09/26/2022

Medicare PECOS Information:

PECOS PAC ID: 3779950852
Enrollment ID: I20230324000733

Medical Identifiers

Medical identifiers for Dr Graham Baluh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881072148	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	32679 (Oklahoma)	Secondary
208600000X	Surgery	32679 (Oklahoma)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Graham Baluh allows following entities to bill medicare on his behalf.

Entity Name	Alaska Native Tribal Health Consortium
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772

News Archive

FDA releases results of ongoing testing efforts to assess the occurrence of PFAS in food supply

Today, the U.S. Food and Drug Administration is providing an update on its ongoing sampling and testing efforts designed to better understand the occurrence of per- and polyfluoroalkyl substances (PFAS) in the food supply.

Study finds low risk of adverse events from cardiac MRI contrast agents

Contrast agents used to improve views of the heart on MRI carry a very low risk of allergic reactions, vomiting and other acute adverse events, according to a large study from Europe published in Radiology: Cardiothoracic Imaging.

Study: Affluent people more likely to undergo bowel cancer screening than deprived counterparts

Affluent people are 50 per cent more likely to take part in bowel cancer screening than their deprived counterparts, according to a study published in the British Journal of Cancer (BJC).

Catheter-directed therapy: First-line treatment option for massive pulmonary embolism

Catheter-directed therapy or catheter-directed thrombolysis-an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs-saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology.

Ophthotech announces data from Fovista Phase 2b trial on wet AMD

Ophthotech Corporation today announced that data from a large, prospective, randomized, controlled Phase 2b clinical trial of Ophthotech's Fovista anti-PDGF therapy (1.5 mg) in patients with neovascular age-related macular degeneration (wet AMD) will be presented during Retina Subspecialty Day at the American Academy of Ophthalmology Annual Meeting (AAO) on Sat., Nov. 10, 2012 at 9:15 a.m.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Graham Baluh is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Graham Baluh, MD 5955 Zeamer Ave, Jber, AK 99506-3702 Ph: (907) 580-1243	Dr Graham Baluh, MD 5955 Zeamer Ave, Jber, AK 99506-3702 Ph: (315) 580-1243

News Archive

FDA releases results of ongoing testing efforts to assess the occurrence of PFAS in food supply

Study finds low risk of adverse events from cardiac MRI contrast agents

Study: Affluent people more likely to undergo bowel cancer screening than deprived counterparts

Affluent people are 50 per cent more likely to take part in bowel cancer screening than their deprived counterparts, according to a study published in the British Journal of Cancer (BJC).

Catheter-directed therapy: First-line treatment option for massive pulmonary embolism

Ophthotech announces data from Fovista Phase 2b trial on wet AMD

Surgery Doctors in Jber, AK

Dr. Justin James Clark, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-1243
Dr. Caleb John Euhus, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-1243
Kaitlin Peace, MD Surgery Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-1243
Dr. Evan Dannhardt, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-1243

Dr Graham Baluh, MD - Medicare Surgery in Jber, AK

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

FDA releases results of ongoing testing efforts to assess the occurrence of PFAS in food supply

Study finds low risk of adverse events from cardiac MRI contrast agents

Study: Affluent people more likely to undergo bowel cancer screening than deprived counterparts

Catheter-directed therapy: First-line treatment option for massive pulmonary embolism

Ophthotech announces data from Fovista Phase 2b trial on wet AMD

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA releases results of ongoing testing efforts to assess the occurrence of PFAS in food supply

Study finds low risk of adverse events from cardiac MRI contrast agents

Study: Affluent people more likely to undergo bowel cancer screening than deprived counterparts

Catheter-directed therapy: First-line treatment option for massive pulmonary embolism

Ophthotech announces data from Fovista Phase 2b trial on wet AMD

Surgery Doctors in Jber, AK